Parametric Portfolio Associates’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q1
$4.57M Buy
55,537
+28,561
+106% +$2.35M ﹤0.01% 1913
2021
Q4
$3.96M Sell
26,976
-22,606
-46% -$3.32M ﹤0.01% 2024
2021
Q3
$8.77M Buy
49,582
+21,063
+74% +$3.73M 0.01% 1456
2021
Q2
$4.61M Buy
28,519
+682
+2% +$110K ﹤0.01% 1896
2021
Q1
$4.77M Sell
27,837
-9,354
-25% -$1.6M ﹤0.01% 2209
2020
Q4
$8.17M Buy
37,191
+9,736
+35% +$2.14M 0.01% 1730
2020
Q3
$4.56M Buy
27,455
+12,538
+84% +$2.08M ﹤0.01% 1962
2020
Q2
$1.7M Buy
14,917
+5,029
+51% +$574K ﹤0.01% 2593
2020
Q1
$760K Sell
9,888
-4,719
-32% -$363K ﹤0.01% 2952
2019
Q4
$1.88M Sell
14,607
-1,085
-7% -$140K ﹤0.01% 2729
2019
Q3
$1.22M Sell
15,692
-2,057
-12% -$160K ﹤0.01% 2925
2019
Q2
$1.83M Buy
17,749
+4,435
+33% +$457K ﹤0.01% 2723
2019
Q1
$976K Buy
+13,314
New +$976K ﹤0.01% 3040
2018
Q4
Sell
-19,623
Closed -$924K 3974
2018
Q3
$924K Sell
19,623
-11,888
-38% -$560K ﹤0.01% 3143
2018
Q2
$1.55M Buy
+31,511
New +$1.55M ﹤0.01% 2830